Редактирование: Young blood (раздел)

== Human trials == <!--T:6-->

<!--T:7-->
Biotech startup [[Special:MyLanguage/Ambrosia|Ambrosia]] ran a human trial from 2016 to 2018.<ref>[https://clinicaltrials.gov/ct2/show/study/NCT02803554 "Young Donor Plasma Transfusion and Age-Related Biomarkers"]. ''ClinicalTrials.gov''.</ref> This was criticised for its risk to participants, requirement for participants to pay thousands of dollars, lack of a control group, and lack of published result data despite the declared intention to publish them.<ref name="huffpo1">Liebelson, Dana; Cook, Jesselyn (29 December 2018). [https://www.huffingtonpost.co.uk/entry/ambrosia-young-blood-plasma-jesse-karmazin_n_5c1bbafce4b0407e9078373c?ri18n=true "He Hawks Young Blood As A New Miracle Treatment. All That's Missing Is Proof."] ''HuffPost''.</ref> Additionally, a 65-year-old participant died the month after the conclusion of the study, which was initially denied but later admitted by Ambrosia's founder.<ref name="huffpo2">Cook, Jesselyn (3 October 2019). [https://www.huffingtonpost.co.uk/entry/ambrosia-young-blood-plasma-jesse-karmazin_n_5c1bbafce4b0407e9078373c?ri18n=true "Notorious ‘Young Blood’ Doctor Claims Dead Patient Faked His Own Death"]. ''HuffPost''.</ref>

<!--T:8-->
Another trial was started in 2018 by the [[Special:MyLanguage/Maharaj Institute|Maharaj Institute]] with estimated completion in 2023. Its plan is to give monthly transfusions of blood plasma from young donors to old and frail participants.<ref>[https://clinicaltrials.gov/ct2/show/NCT03458429 "Safety, Efficacy of FFP From Healthy Donors to AmeliorateFrailty and Enhance Immune Function in Older Individuals"]. ''ClinicalTrials.gov''.</ref> The trial also has no placebo group and asked for payment to participate.<ref>Robbins, Rebecca (2 March 2018). [https://www.scientificamerican.com/article/young-blood-transfusions-are-on-the-menu-at-society-gala/ "Young-Blood Transfusions Are on the Menu at Society Gala"]. ''STAT''.</ref>

<!--T:9-->
The [[Special:MyLanguage/Young Blood Institute|Young Blood Institute]] have also run trials with blood plasma.<ref>Basu, Tanya; Weill, Kelly (22 February 2019). [https://www.thedailybeast.com/fda-warns-dont-give-these-companies-your-young-blood "FDA Warns: Don't Give These Companies Your 'Young Blood'"]. ''The Daily Beast''.</ref>
Описание	Что вы вводите	Что вы получаете
Курсив	''Курсивное начертание''	Курсивное начертание
Полужирный	'''Полужирное начертание'''	Полужирное начертание
Полужирный курсив	'''''Полужирный курсив'''''	Полужирный курсив